BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

Auxilium Pharmaceuticals Enters Oversold Territory (AUXL)

Following
This article is more than 10 years old.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of Auxilium Pharmaceuticals Inc (NASD: AUXL) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $23.3956 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 42.0. A bullish investor could look at AUXL's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of AUXL shares:

Looking at the chart above, AUXL's low point in its 52 week range is $13.87 per share, with $32.89 as the 52 week high point — that compares with a last trade of $23.69. Find out what 9 other oversold stocks you need to know about »

According to the ETF Finder at ETFChannel.com, AUXL makes up 3.05% of the SPDR S&P Pharmaceuticals ETF (AMEX: XPH) which is trading lower by about 0.8% on the day Tuesday.


Special Offer: Manage the risks of the markets better with a free 30 day trial to the Strategic Risk Management System.